2015;10(8): e0133466. 420. Lee MS, Chen W, Zhang Z, et al. Atrial brillation and atrial utter in pregnant women a population-based study. J Am Heart Assoc. 2016;5(4):e003182. 421. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S-e736S. 422. Goland S, Elkayam U. Anticoagulation in pregnancy. Cardiol Clin. 2012;30(3):395-405. 423. Conti E, Zezza L, Ralli E, et al. Pulmonary embolism in pregnancy. J Thromb Thrombolysis. 2014;37(3):251-270. 424. Orme ML, Lewis PJ, de Swiet M, et al. May mothers given warfarin breast-feed their infants? Br Med J. 1977;1(6076):1564-1565. 425. McKenna R, Cole ER, Vasan U. Is warfarin sodium contraindicated in the lactating mother? J Pediatr. 1983;103(2):325-327. 426. Houwert-de Jong M, Gerards LJ, Tetteroo-Tempelman CA, de Wolff FA. May mothers taking acenocoumarol breast feed their infants? Eur J Clin Pharmacol. 1981;21(1):61-64. 427. Fondevila CG, Meschengieser S, Blanco A, Pe alva L, Lazzari MA. Effect of acenocoumarine on the breast-fed infant. Thrombosis Res. 1989;56(1):29-36. 428. Boriani G, Savelieva I, Dan GA, et al. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical signi cance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Paci c Heart Rhythm Society. Europace. 2015;17(8):1169-1196. 429. Yang F, Hellyer JA, Than C, et al. Warfarin utilisation and anticoagulation control in patients with atrial brillation and chronic kidney disease. Heart. 2017;103(11):818-826. 430. McAlister FA, Wiebe N, Jun M, et al. Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease? Can J Cardiol. 2017;33(2):243-252. 431. Chao TF, Liu CJ, Wang KL, et al. 